We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




C-reactive Protein Varies According to Genetic Heritage

By LabMedica International staff writers
Posted on 20 Oct 2010
C-reactive protein is found in the blood and the levels rise in response to inflammation and is linked to a higher risk for heart disease.

Even though high C-reactive protein (CRP) blood levels have been associated with a greater chance of developing heart disease, the link is uncertain if the association is casual. More...
It is synthesized by the liver in response to factors released by adipocytes (fat cells). Scientists are not sure whether the CRP-lowering effects of statins have any health benefits.

In a study, carried out at the University College London (UCL; London, UK), investigators examined data on 221,287 individuals from 89 published studies. The risk cut-off point used was 2 mg/L based on the findings of the US Food and Drug Administration (FDA; Silver Spring, MD, USA) for males over 50 and females over 60 who have one other heart disease risk factor as well as CRP values over the this level.

The scientists found that CRP blood levels vary according to ethnicity, even after such factors as age and body mass index (BMI) has been taken into account. They found the following geometric mean CRP levels according to ancestry: 2.6 mg/L in 18,585 African-Americans; 2.51 mg/L in 5,049 Hispanics; 2.34 mg/L in 1,053 South Asians; 2.03 mg/L in 104,949 Caucasians; and 1.01 mg/L in 39,521 East Asians. The order remained unchanged when the investigators calculated the probability that individuals in each ethnic group would exceed the 2 mg/L CRP threshold at any age. Over 50% of Hispanics and African-Americans were over the 2 mg/L CRP threshold at the age of 50, compared to fewer than half of East Asians. At the age of 60 under 40% of East Asians and nearly two-thirds of African-Americans and Hispanics would likely have a CRP greater than 2 mg/L.

Tina Shah, Ph.D., coauthor of the study, noted that, "The difference in average population CRP values in populations of different ancestry are sufficiently large as to have bearing on clinical management and statin eligibility based on single CRP cut-off point values." The study was published online on September 28, 2010 in Circulation: Cardiovascular Genetics.

Related Links:
University College London
FDA



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.